603127 昭衍新药
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--019,52922,59825,289
投资性房地产0--0000
固定资产677,346-2.79%696,786583,319590,214493,153
在建工程394,6296.97%368,927342,008277,735127,361
无形资产294,695-1.28%298,514292,380299,536137,193
商誉137,841-0.14%138,037136,007133,739122,431
其他非流动资产2,856,387-0.22%2,862,6911,531,9503,111,9881,817,166
4,360,898-0.09%4,364,9552,905,1924,435,8102,722,593

流动资产
货币资金676,571-29.90%965,2032,862,9122,916,8484,154,099
应收账款178,912-1.25%181,168206,014199,437107,606
存货1,528,4053.37%1,478,5471,863,0822,194,606700,587
其他流动资产2,679,87311.37%2,406,2802,189,959617,516852,192
5,063,7610.65%5,031,1987,121,9675,928,4065,814,484

流动负债
短期借款0--0000
应付票据0--0000
应付帐款44,537-11.32%50,22243,323127,30953,644
其他流动负债1,053,122-0.68%1,060,3461,424,0421,716,9531,160,598
1,097,659-1.16%1,110,5691,467,3651,844,2621,214,242
流动资产净值3,966,1021.16%3,920,6295,654,6024,084,1444,600,242
资产总额减流动负债8,326,9990.50%8,285,5848,559,7958,519,9537,322,835

非流动负债
长期借款0--003,2814,939
应付债券0--0000
其他非流动负债217,7935.52%206,396278,754325,807173,460
217,7935.52%206,396278,754329,087178,399

总权益
    实收股本749,4770.00%749,477749,889535,679381,246
    储备项目7,359,3590.41%7,329,3417,529,4277,648,0236,754,968
股东权益8,108,8360.37%8,078,8198,279,3168,183,7017,136,214
非控股权益3700.00%3701,7257,1658,222